List of directors and their roles and functions
Filed with HKEX · Stock code 2592 · · 2 pages · English
With effect from 23 September 2026, the members of the board (the “Board”) of directors (the “Directors”) of Cloudbreak Pharma Inc. (the “Company”) will be as set out below: Executive Directors Dr. NI Jinsong (Chairman and Chief Executive Officer) Mr. DINH Son Van (Chief Operating Officer) Dr. YANG Rong (Chief Scientific Officer) Non-executive Directors Dr. LI Jun Zhi Mr. CAO Xu (曹旭) Mr. XIA Zhido
Cloudbreak Pharma, Inc. on 6ix
Earlier from Cloudbreak Pharma
- Appointment of independent non-executive directors and continued suspension of trading
- Business updates and supplemental announcement in relation to 2025 annual report
- Suspension of trading
- Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
- Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Later from Cloudbreak Pharma
- Formation of an independent Special committee; delay in publication and despatch of 2026 interim report; and continued suspension of trading
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Cloudbreak Pharma into a list and get an email when it puts out news.
Follow Cloudbreak Pharma